ÀÚ½ÅÀÇ ÁúȯÀ» ÀÌÇØÇÒ ¼ö ÀÖ°Ô ÇÏ´Â Á¤½Å¾à¹°Ä¡·á Àü¹®°¡
| Á¦ ¸ñ | Preventive effect of aripiprazole once-monthly on relapse into mood episodes in bipolar disorder: A multicenter, one-year, retrospective, mirror image study |
|---|---|
| ¹ßÇ¥³âµµ | 2024 |
| ¹ßÇ¥Áö | Journal of Affective Disorder |
| Á¦ ¸ñ | Prevalence and Comorbidities of Adult Attention-deficit/hyperactivity Disorder in a Community Sample from Korea |
|---|---|
| ¹ßÇ¥³âµµ | 2023 |
| ¹ßÇ¥Áö | Clinical Psychopharmacology and Neuroscience |
| Á¦ ¸ñ | The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review |
|---|---|
| ¹ßÇ¥³âµµ | 2022 |
| ¹ßÇ¥Áö | PLoS One |
| Á¦ ¸ñ | Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression-A Literature Review |
|---|---|
| ¹ßÇ¥³âµµ | 2020 |
| ¹ßÇ¥Áö | International Journal of Molecular Science |
| Á¦ ¸ñ | Clinical correlates associated with the long-term response of bipolar disorder patients to lithium, valproate or lamotrigine: A retrospective study |
|---|---|
| ¹ßÇ¥³âµµ | 2020 |
| ¹ßÇ¥Áö | PLoS One |
| Á¦ ¸ñ | Paroxetine versus Venlafaxine and Escitalopram in Korean Patients with Major Depressive Disorder: A Randomized, Rater-blinded, Six-week Study. |
|---|---|
| ¹ßÇ¥³âµµ | 2017 |
| ¹ßÇ¥Áö | Clinical Psychopharmacology and Neuroscience |
| Á¦ ¸ñ | Effects of switching to aripiprazole from current atypical antipsychotics on subsyndromal symptoms and tolerability in patients with bipolar disorder |
|---|---|
| ¹ßÇ¥³âµµ | 2016 |
| ¹ßÇ¥Áö | International Clinical Psychopharmacology |

¿ì¿µ¼· ¹Ú¿ø¸í Á¤½Å°Ç°ÀÇÇаú´Â 20³â ÀÌ»ó ´ëÇк´¿ø¿¡¼ ±³¼ö·Î ÀçÁ÷ÇÏ¸ç ¾ç±Ø¼ºÀå¾Ö, ¿ì¿ïÁõ, ¼ºÀÎ ADHD µî ´Ù¾çÇÑ Á¤½ÅÁúȯÀÇ ¾à¹°Ä¡·á¸¦ ¿¬±¸Çؿ Àü¹®°¡µéÀÌ ÇÔ²²ÇÏ´Â º´¿øÀ¸·Î, Á¤È®ÇÑ Áø´Ü°ú °úÇÐÀû ±Ù°Å ¹× ȯÀÚ °³ÀΠƯ¼º¿¡ ¹ÙÅÁÀ» µÐ Ä¡·á¸¦ ÅëÇØ ȯÀÚÀÇ »î°ú ¸¶À½À» Ä¡À¯ÇÕ´Ï´Ù.
¼¿ïƯº°½Ã ¿µµîÆ÷±¸ 63·Î 36, ¸®¹öŸ¿ö 601È£